[1]张　赟,郭艳平,张向东.丁苯酞静脉注射序贯口服治疗血管性认知障碍伴高同型半胱氨酸血症疗效观察[J].新乡医学院学报,2022,39(6):552-556.[doi:10.7683/xxyxyxb.2022.06.011]
　ZHANG Yun,GUO Yanping,ZHANG Xiangdong.Efficacy of butylphthalide intravenously and sequentially oral in the treatment of vascular cognitive impairment with hyperhomocysteinemia[J].Journal of Xinxiang Medical University,2022,39(6):552-556.[doi:10.7683/xxyxyxb.2022.06.011]
点击复制

丁苯酞静脉注射序贯口服治疗血管性认知障碍伴高同型半胱氨酸血症疗效观察
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
39
期数:
2022年6
页码:
552-556
栏目:
临床研究
出版日期:
2022-06-05

文章信息/Info

Title:
Efficacy of butylphthalide intravenously and sequentially oral in the treatment of vascular cognitive impairment with hyperhomocysteinemia
作者:
张　赟; 郭艳平; 张向东
（安阳市人民医院神经内科，河南　安阳　455000）
Author(s):
ZHANG Yun; GUO Yanping; ZHANG Xiangdong
(Department of Neurology,Anyang People′s Hospital,Anyang 455000,Henan Province,China)
关键词:
血管性认知障碍; 高同型半胱氨酸血症; 丁苯酞; 认知功能
Keywords:
vascular cognitive impairment; hyperhomocysteinemia; butylphthalide; cognitive function
分类号:
R749.1
DOI:
10.7683/xxyxyxb.2022.06.011
文献标志码:
A
摘要:
目的　探讨丁苯酞静脉注射序贯口服治疗血管性认知障碍（VCI）伴高同型半胱氨酸血症（HHcy）患者的临床疗效。方法　选择2019年5月至2020年5月安阳市人民医院收治的100例VCI伴HHcy患者为研究对象，根据治疗方法将患者分为观察组和对照组，每组50例。对照组患者给予常规药物治疗，包括口服阿司匹林肠溶片，每次100 mg，每日1次；口服马来酸依那普利片，每次20 mg，每日1次；口服阿托伐他汀钙片，每次20 mg，每日1次；连续治疗3个月。观察组患者在常规药物治疗基础上给予丁苯酞氯化钠注射液100 mL（含丁苯酞25 mg），静脉滴注，每日2次，连续治疗14 d后改为口服丁苯酞软胶囊0.2 g，每日3次，累计治疗3个月。治疗后2组患者随访6个月。分别于治疗前及治疗1、3个月和治疗后3、6个月，采用简易智力状态检查（MMSE）量表评估患者的智力状态；采用蒙特利尔认知评估（MoCA）量表评估患者的认知功能；采用日常生活能力量表（ADL）评估患者的日常生活能力。结果　对照组患者治疗3个月及治疗后3、6个月的MMSE评分显著高于治疗前（P<0.05）；观察组患者治疗1、3个月及治疗后3、6个月的MMSE评分显著高于治疗前（P<0.05）；治疗1、3个月及治疗后3、6个月，2组患者的MMSE评分均呈升高趋势，且观察组患者的MMSE评分显著高于对照组（P<0.05）。2组患者治疗3个月及治疗后3、6个月的MoCA评分显著高于治疗前（P<0.05）；治疗1、3个月及治疗后3、6个月，2组患者的MoCA评分均呈升高趋势（P<0.05）；治疗3个月及治疗后3、6个月，观察组患者的MoCA评分显著高于对照组（P<0.05）。2组患者治疗1、3个月及治疗后3、6个月的ADL评分均显著高于治疗前（P<0.05）；治疗1、3个月及治疗后3、6个月，2组患者的ADL评分均呈升高趋势（P<0.05），且观察组患者的ADL评分显著高于对照组（P<0.05）。结论　常规药物联合丁苯酞静脉注射序贯口服治疗可有效改善VCI伴HHcy患者智力状态、认知功能，提高患者日常生活能力，临床疗效显著。
Abstract:
Objective　To explore the clinical efficacy of butylphthalide intravenously and sequentially oral in the treatment of vascular cognitive impairment (VCI) with hyperhomocysteinemia(HHcy).Methods　A total of 100 patients with VCI and HHcy admitted to the Anyang People′s Hospital from May 2019 to May 2020 were selected as the research objects.According to treatment methods,the patients were divided into control group and observation group,with 50 cases in each group.The patients in the control group were given conventional drug therapy,included taking aspirin enteric-coated tablets orally,100 mg each time,once a day;taking enalapril maleate tablets orally,5 mg each time,once a day;taking atorvastatin calcium tablets orally,20 mg each time,once a day;the treatment lasted for 3 months.On the basis of routine drug treatment,the patients in the observation group were given butylphthalide sodium chloride injection intravenously,100 mL each time (containing 25 mg of butylphthalide),twice a day;after 14 days of continuous treatment,the patients were changed to take butylphthalide soft capsules orally,0.2 g each time,3 times a day,and the treatment lasted for 3 months.After treatment,the patients in the two groups were followed up for 6 months.Before treatment,after 1 and 3 months of treatment,at 3 and 6 months after treatment,the mental state of the patients was assessed by the mini-mental state examination (MMSE) scale;the cognitive function of the patients was evaluated by the montreal cognitive assessment (MoCA) scale;the ability of daily living of patients was evaluated by the activities of daily living scale (ADL).Results　The MMSE scores of patients in the control group after 3 months of treatment and at 3,6 months after treatment were significantly higher than those before treatment (P<0.05);the MMSE scores of patients in the observation group after 1,3 months of treatment and at 3,6 months after treatment were significantly higher than those before treatment (P<0.05);after 1,3 months of treatment and at 3,6 months after treatment,the MMSE scores of patients in the two groups showed a significant upward trend,and the MMSE score of patients in the observation group was significantly higher than that in the control group (P<0.05).The MoCA scores of patients in the two groups after 3 months of treatment and at 3,6 months after treatment were significantly higher than those before treatment (P<0.05);after 1,3 months of treatment and at 3,6 months after treatment,the MoCA scores of patients in the two groups showed a significant upward trend;after 3 months of treatment and at 3,6 months after treatment,the MoCA score of patients in the observation group was significantly higher than that in the control group (P<0.05).The ADL scores of patients in the two groups after 1,3 months of treatment and at 3,6 months after treatment were significantly higher than those before treatment (P<0.05);after 1,3 months of treatment and at 3,6 months after treatment,the ADL scores of patients in the two groups showed a significant upward trend (P<0.05),and the ADL score of patients in the observation group was significantly higher than that in the control group (P<0.05).Conclusion　Conventional drugs combined with butylphthalide intravenously and sequentially oral therapy can effectively improve the mental state,cognitive function and daily living ability of patients with VCI and HHcy,and the clinical effect is significant.

参考文献/References:

［1］　CZAK C,KOVCS T,UNGVARI Z,et al.Retinal biomarkers for alzheimer′s disease and vascular cognitive impairment and dementia (vcid):implication for early diagnosis and prognosis［J］.Geroscience,2020,42(6):1499-1525.
［2］　MEGURO K,DODGE H H.Vascular mild cognitive impairment:identifying disease in community-dwelling older adults,reducing risk factors,and providing support,the osaki-tajiri and kurihara Projects［J］.J Alzheimers Dis,2019,70(1):293-302.
［3］　赵永红,张鸿儒.同型半胱氨酸与老年患者血管性认知功能障碍的临床研究［J］.中国药物与临床,2020,20(19):3232-3234.
ZHAO Y H,ZHANG H R.A clinical study on homocysteine and vascular cognitive dysfunction in elderly patients［J］.Chin Remed Clin,2020,20(19):3232-3234.
［4］　CHIANG C P,CHANG J Y,WANG Y P,et al.Atrophic glossitis:etiology,serum autoantibodies,anemia,hematinic deficiencies,hyperhomocysteinemia,and management［J］.J Formos Med Assoc,2020,119(4):774-780.
［5］　罗志秀,刘正芳,曾晓云,等.老年无症状性颈动脉狭窄患者认知障碍影响因素分析及联合丁苯酞治疗效果研究［J］.中华老年心脑血管病杂志,2020,22(7):729-733.
LUO Z X,LIU Z F,ZENG X Y,et al.Analysis of influencing factors of cognitive impairment in elderly patients with asymptomatic carotid stenosis and study on the effect of combined butylphthalide treatment［J］.Chin J Geriatr Heart Brain Vessel Dis,2020,22(7):729-733.
［6］　周黎,项予良,郭昭婷,等.银杏内酯注射液对比丁苯酞注射液治疗大动脉粥样硬化性缺血性脑卒中的最小成本分析［J］.中国药房,2020,31(18):2235-2239.
ZHOU L,XIANG Y L,GUO Z T,et al.Minimal cost analysis of ginkgolide injection versus butylphthalide injection in the treatment of large atherosclerotic ischemic stroke［J］.China Pharmacy,2020,31(18):2235-2239.
［7］　国家卫生计生委脑卒中防治工程委员会,脑卒中防治系列指导规范编审委员会.2016中国血管性认知障碍诊疗指导规范［J］.心脑血管病防治,2017,17(1):3-6.
NATIONAL HEALTH AND FAMILY PLANNING COMMISSION STROKE PREVENTION AND CONTROL ENGINEERING COMMITTEE,STROKE PREVENTION AND CONTROL SERIES GUIDELINES EDITING AND REVIEW COMMITTEE.2016 guidelines for diagnosis and treatment of vascular cognitive impairment in China［J］.Prev Treatment Cardiov Cerebrov Dis,2017,17(1):3-6.
［8］　MYRBERG K,HYDN L C,SAMUELSSON C.The mini-mental state examination (MMSE) from a language perspective:an analysis of test interaction［J］.Clin Linguist Phon,2020,34(7):652-670.
［9］　RIBEIRO M,DURAND T,ROUSSEL M,et al.Sensitivity of the montreal cognitive assessment in screening for cognitive impairment in patients with newly diagnosed high-grade glioma［J］.J Neurooncol,2020,148(2):335-342.
［10］　王军英,段毅,赵平平,等.丁苯酞氯化钠注射液联合经颅磁刺激对急性脑梗死后血管性认知功能障碍的影响及机制研究［J］.河北医药,2020,42(22):3459-3461.
WANG J Y,DUAN Y,ZHAO P P,et al.Effects and mechanism of butylphthalide sodium chloride injection combined with transcranial magnetic stimulation on vascular cognitive dysfunction after acute cerebral infarction［J］.Hebei Med J,2020,42(22):3459-3461.
［11］　KERKHOFS D,VAN HAGEN B T,MILANOVA I V,et al.Pharmacological depletion of microglia and perivascular macrophages prevents vascular cognitive impairment in ang II-induced hypertension［J］.Theranostics,2020,10(21):9512-9527.
［12］　DUBCHENKO E A,IVANOV A V,BOIKO A N,et al.Hyperhomocysteinemia and endothelial dysfunction in patients with cerebral vascular and autoimmune diseases［J］.Zh Nevrol Psikhiatr Im S S Korsakova,2019,119(11):133-138.
［13］　NGUYEN D H,CUNNINGHAM J T,SUMIEN N.Estrogen receptor involvement in vascular cognitive impairment and vascular dementia pathogenesis and treatment［J］.Geroscience,2021,43(1):159-166.
［14］　RYAN J,STOREY E,MURRAY A M,et al.Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline［J］.Neurology,2020,95(3):320-331.
［15］　NIU X L,JIANG X,XU G D,et al.DL-3-n-butylphthalide alleviates vascular cognitive impairment by regulating endoplasmic reticulum stress and the Shh/Ptch1 signaling-pathway in rats［J］.J Cell Physiol,2019,234(8):12604-12614.
［16］　MARCO-CONTELLES J,ZHANG Y.From seeds of apium graveolens linn.to a cerebral ischemia medicine:the long journey of 3-n-butylphthalide［J］.J Med Chem,2020,63(21):12485-12510.
［17］　UPPAKARA K,JAMORNWAN S,DUAN L X,et al.Novel α-lipoic acid/3-n-butylphthalide conjugate enhances protective effects against oxidative stress and 6-ohda induced neuronal damage［J］.ACS Chem Neurosci,2020,11(11):1634-1642.

相似文献/References:

[1]郭跃伟,杨瑞,张哲莹,等.高同型半胱氨酸血症大鼠主动脉平滑肌细胞中巨噬细胞炎性蛋白1α和C-C型趋化因子受体1的表达[J].新乡医学院学报,2009,26(01):004.
[2]黄晓芸,刘　军,黄凯帆,等.血管性认知障碍患者血清脂蛋白相关磷脂酶A2水平变化及其对认知障碍的预测价值[J].新乡医学院学报,2021,38(1):031.[doi:10.7683/xxyxyxb.2021.01.006]
　HUANG Xiaoyun,LIU Jun,HUANG Kaifan,et al.Changes of serum lipoprotein phospholipase A2 levels in patients with vascular cognitive impairment and its predictive value in cognitive impairment[J].Journal of Xinxiang Medical University,2021,38(6):031.[doi:10.7683/xxyxyxb.2021.01.006]
[3]张雪儿,郑　娜,梁紫君,等.微RNA在血管性认知障碍中的作用研究进展[J].新乡医学院学报,2021,38(9):897.[doi:10.7683/xxyxyxb.2021.09.022]
[4]陈萌珂,张黎军,王园春,等.血清可溶性细胞间黏附分子-1水平与急性脑梗死患者血管性认知障碍的相关性[J].新乡医学院学报,2020,37(7):666.[doi:10.7683/xxyxyxb.2020.07.016]
　CHEN Mengke,ZHANG Lijun,WANG Yuanchun,et al.Correlation between serum soluble intercellular adhesion molecule-1 level and vascular cognitive impairment in patients with acute cerebral infarction[J].Journal of Xinxiang Medical University,2020,37(6):666.[doi:10.7683/xxyxyxb.2020.07.016]

更新日期/Last Update: 2022-06-05